JamesRHarknessMD
Cardiology • Murray, UTAdult Congenital Heart Disease, Interventional Cardiology
Interventional Cardiologist at Intermountain Healthcare
Dr. Harkness is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5169 S Cottonwood St
Ste 520
Murray, UT 84107Phone+1 801-507-3500
Education & Training
Massachusetts General HospitalFellowship, Interventional Cardiology, 2014 - 2015- Massachusetts General HospitalFellowship, Interventional Cardiology, 2013 - 2014
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2010 - 2013
Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2009- Johns Hopkins University School of MedicineClass of 2006
Certifications & Licensure
NH State Medical License 2014 - Present
UT State Medical License 2015 - 2026
MA State Medical License 2008 - 2016
MD State Medical License 2011 - 2014- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Residual or recurrent mitral regurgitation predicts mortality following transcatheter edge-to-edge mitral valve repair.Stephen H McKellar, James Harkness, Bruce B Reid, Nishant K Sekaran, Heidi T May
JTCVS Open. 2023-12-01 - 3 citationsTranscatheter mitral valve in ring, hazards of long anterior mitral leaflet and 3-dimensional rings.Nishant K. Sekaran, Benjamin D. Horne, John R. Doty, Bruce B. Reid, Edward Miner
Catheterization and Cardiovascular Interventions. 2021-02-01 - 18 citationsTranscatheter Aortic Valve-in-Valve Replacement for Degenerated Stentless Bioprosthetic Aortic Valves: Results of a Multicenter Retrospective AnalysisMatthew J. Miller, Mandy Snyder, Benjamin D. Horne, James R. Harkness, John R. Doty
JACC. Cardiovascular Interventions. 2019-07-08
Press Mentions
BioTrace Medical Announces First U.S. Patients Treated with Company’s Innovative Temporary Pacing LeadDecember 19th, 2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
